Everest Re (RE) Tops Q1 EPS by 71c
Tweet
Share
E-mail
Get Alerts RE Hot Sheet
Price: $351.28 --0%
Financial Fact:
Other net realized capital gains (losses): 1.25M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Other net realized capital gains (losses): 1.25M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Everest Re (NYSE: RE) reported Q1 EPS of $6.49, $0.71 better than the analyst estimate of $5.78.
For earnings history and earnings-related data on Everest Re (RE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ackman adds Netflix, Visa and Mastercard in portfolio revamp
- Innovative Solutions & Support (ISSC) Tops Q3 EPS by 10c
- Lucid Diagnostics Inc. (LUCD) Reports In-Line Q2 EPS
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
